|
π
|
Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.
10 auth.
J. Gallant,
S. Staszewski,
A. Pozniak,
E. Dejesus,
J. Suleiman,
Michael D. Miller,
...
D. Coakley,
B. Lu,
J. Toole,
A. Cheng
|
10 |
2004 |
10
π
|
|
π
|
The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation
337 auth.
F. Pereyra,
Xiaoming Jia,
P. McLaren,
A. Telenti,
P. D. de Bakker,
B. Walker,
S. Ripke,
C. Brumme,
S. Pulit,
M. Carrington,
C. Kadie,
J. Carlson,
D. Heckerman,
R. Graham,
R. Plenge,
...
S. Deeks,
Lauren Gianniny,
G. Crawford,
J. Sullivan,
Elena Gonzalez,
Leela R. L. Davies,
Amy L. Camargo,
Jamie M Moore,
Nicole L Beattie,
Supriya Gupta,
A. Crenshaw,
N. Burtt,
C. Guiducci,
N. Gupta,
Xiaojiang Gao,
Y. Qi,
Y. Yuki,
A. Piechocka-Trocha,
Emily Cutrell,
R. Rosenberg,
K. Moss,
P. Lemay,
Jessica O'Leary,
T. Schaefer,
Pranshu Verma,
I. Toth,
Brian L Block,
Brett M. Baker,
A. Rothchild,
J. Lian,
J. Proudfoot,
D. Alvino,
S. Vine,
M. Addo,
Todd M. Allen,
M. Altfeld,
M. Henn,
S. Le Gall,
H. Streeck,
D. Haas,
D. Kuritzkes,
G. Robbins,
R. Shafer,
R. Gulick,
C. Shikuma,
R. Haubrich,
S. Riddler,
P. Sax,
E. Daar,
H. Ribaudo,
B. Agan,
Shanu Agarwal,
R. Ahern,
Brady Allen,
Sherly Altidor,
E. Altschuler,
S. Ambardar,
K. Anastos,
B. Anderson,
Val Anderson,
U. Andrady,
D. Antoniskis,
D. Bangsberg,
D. Barbaro,
W. Barrie,
J. Bartczak,
S. Barton,
P. Basden,
N. Basgoz,
S. Bazner,
Nicholaos C. Bellos,
A. M. Benson,
J. Berger,
N. Bernard,
A. Bernard,
Christopher E Birch,
S. Bodner,
R. Bolan,
Emilie T Boudreaux,
Meg Bradley,
J. Braun,
Jon E Brndjar,
S. Brown,
Katherine Brown,
Sheldon T. Brown,
J. Burack,
L. Bush,
Virginia Cafaro,
Omobolaji Campbell,
John Campbell,
R. Carlson,
J. Carmichael,
K. Casey,
C. Cavacuiti,
G. Celestin,
Steven T Chambers,
N. Chez,
L. Chirch,
P. Cimoch,
Daniel E. Cohen,
Lillian E Cohn,
B. Conway,
D. Cooper,
B. Cornelson,
D. T. Cox,
M. Cristofano,
G. Cuchural,
Julie L. Czartoski,
J. Dahman,
J. S. Daly,
B. Davis,
K. Davis,
Sheila M Davod,
E. Dejesus,
Craig A. Dietz,
Eleanor Dunham,
M. Dunn,
T. Ellerin,
J. Eron,
J. Fangman,
Claire E Farel,
Helen Ferlazzo,
S. Fidler,
Anita Fleenor-Ford,
Renee E. Frankel,
K. Freedberg,
N. French,
J. Fuchs,
Jon Fuller,
Jonna Gaberman,
J. Gallant,
R. Gandhi,
Efrain Garcia,
D. Garmon,
J. Gathe,
C. Gaultier,
Wondwoosen Gebre,
F. Gilman,
I. Gilson,
P. Goepfert,
M. Gottlieb,
C. Goulston,
R. Groger,
T. Gurley,
S. Haber,
R. Hardwicke,
W. Hardy,
P. Harrigan,
T. Hawkins,
S. Heath,
F. Hecht,
W. K. Henry,
Melissa Hladek,
R. Hoffman,
J. Horton,
R. Hsu,
G. Huhn,
P. Hunt,
M. Hupert,
M. Illeman,
H. Jaeger,
Robert M. Jellinger,
M. John,
Jennifer A. Johnson,
K. L. Johnson,
Heather Johnson,
Kay Johnson,
Jennifer Joly,
W. Jordan,
C. Kauffman,
H. Khanlou,
Robert K Killian,
A. Kim,
David D. Kim,
Clifford Kinder,
J. Kirchner,
L. Kogelman,
E. Kojic,
P. Korthuis,
W. Kurisu,
D. Kwon,
M. Lamar,
H. Lampiris,
M. Lanzafame,
M. Lederman,
David M. Lee,
Jean Lee,
Marah J Lee,
Edward Lee,
Janice Lemoine,
J. Levy,
J. Llibre,
Michael Liguori,
S. Little,
Anne Y. Liu,
A. J. Lopez,
Mono R Loutfy,
D. Loy,
Debbie Y Mohammed,
A. Man,
M. Mansour,
V. Marconi,
M. Markowitz,
R. Marques,
Jeffrey N. Martin,
H. Martin,
K. Mayer,
M. McElrath,
Theresa A. Mcghee,
B. McGovern,
K. McGowan,
D. McIntyre,
G. McLeod,
P. Menezes,
G. Mesa,
C. Metroka,
D. Meyer-Olson,
Andy O. Miller,
K. Montgomery,
K. Mounzer,
Ellen H. Nagami,
Iris Nagin,
R. Nahass,
Margret O Nelson,
C. Nielsen,
David L Norene,
D. OβConnor,
B. Ojikutu,
J. Okulicz,
Olakunle Oladehin,
Edward Oldfield,
S. Olender,
M. Ostrowski,
W. Owen,
Eunice Pae,
J. Parsonnet,
A. M. Pavlatos,
Aaron Perlmutter,
Michael N Pierce,
Jon Pincus,
L. Pisani,
L. Price,
L. Proia,
R. Prokesch,
Heather Calderon Pujet,
M. Ramgopal,
Almas Rathod,
M. Rausch,
J. Ravishankar,
F. Rhame,
C. S. Richards,
D. Richman,
B. RodΓ©s,
M. RodrΓguez,
R. C. Rose,
E. Rosenberg,
Daniel J. Rosenthal,
P. E. Ross,
David S. Rubin,
E. Rumbaugh,
L. Saenz,
Michelle R. Salvaggio,
William C. Sanchez,
V. Sanjana,
S. Santiago,
Wolfgang Schmidt,
H. Schuitemaker,
P. Sestak,
P. Shalit,
W. Shay,
V. Shirvani,
Vanessa I Silebi,
J. M. Sizemore,
P. Skolnik,
M. SokolβAnderson,
J. Sosman,
P. Stabile,
J. Stapleton,
Sheree Starrett,
Francine Stein,
H. Stellbrink,
F. L. Sterman,
V. Stone,
D. Stone,
G. Tambussi,
R. Taplitz,
E. Tedaldi,
W. Theisen,
Richard Torres,
L. Tosiello,
C. Tremblay,
M. Tribble,
P. D. Trinh,
Alice Tsao,
P. Ueda,
Anthony J. Vaccaro,
E. Valadas,
T. Vanig,
I. Vecino,
Vilma M Vega,
Wenoah Veikley,
B. Wade,
C. Walworth,
C. Wanidworanun,
D. Ward,
D. A. Warner,
R. Weber,
D. Webster,
S. Weis,
D. Wheeler,
D. White,
E. Wilkins,
A. Winston,
C. Wlodaver,
A. V. vanβt Wout,
David P Wright,
O. Yang,
David L. Yurdin,
Brandon W Zabukovic,
K. Zachary,
B. Zeeman,
Mengmeng Zhao
|
10 |
2010 |
10
π
|
|
π
|
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.
12 auth.
J. Gallant,
E. Dejesus,
J. Arribas,
A. Pozniak,
B. Gazzard,
R. Campo,
...
B. Lu,
D. Mccoll,
S. Chuck,
J. Enejosa,
J. Toole,
A. Cheng
|
9 |
2006 |
9
π
|
|
π
|
Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
22 auth.
E. Lawitz,
M. Sulkowski,
R. Ghalib,
M. RodriΜguez-Torres,
Z. Younossi,
A. Corregidor,
E. Dejesus,
Brian L. Pearlman,
M. Rabinovitz,
N. Gitlin,
...
Joseph K. Lim,
P. Pockros,
John D. Scott,
B. Fevery,
Tom Lambrecht,
S. Ouwerkerk-Mahadevan,
K. Callewaert,
W. Symonds,
G. Picchio,
K. Lindsay,
M. Beumont,
I. Jacobson
|
9 |
2014 |
9
π
|
|
π
|
Maraviroc for previously treated patients with R5 HIV-1 infection.
18 auth.
R. Gulick,
J. Lalezari,
J. Goodrich,
N. Clumeck,
E. Dejesus,
A. Horban,
J. Nadler,
B. Clotet,
A. Karlsson,
M. Wohlfeiler,
...
J. B. Montana,
Mary Mchale,
J. Sullivan,
C. Ridgway,
S. Felstead,
M. Dunne,
E. van der Ryst,
H. Mayer
|
9 |
2008 |
9
π
|
|
π
|
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
16 auth.
J. Lennox,
E. Dejesus,
A. Lazzarin,
R. Pollard,
J. Madruga,
D. Berger,
Jing Zhao,
Xia Xu,
A. Williams-Diaz,
A. Rodgers,
...
Richard J. O. Barnard,
Michael D. Miller,
M. Dinubile,
B. Nguyen,
R. Leavitt,
P. Sklar
|
9 |
2009 |
9
π
|
|
π
|
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.
30 auth.
S. Hammer,
M. Sobieszczyk,
H. Janes,
S. Karuna,
M. Mulligan,
D. Grove,
B. Koblin,
S. Buchbinder,
M. Keefer,
G. Tomaras,
N. Frahm,
J. Hural,
C. Anude,
B. Graham,
M. Enama,
...
Elizabeth Adams,
E. Dejesus,
R. Novak,
I. Frank,
Carter Bentley,
S. Ramirez,
Rong Fu,
R. Koup,
J. Mascola,
G. Nabel,
D. Montefiori,
J. Kublin,
M. McElrath,
L. Corey,
P. Gilbert
|
9 |
2013 |
9
π
|
|
π
|
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
24 auth.
P. Sax,
D. Wohl,
M. Yin,
F. Post,
E. Dejesus,
M. Saag,
A. Pozniak,
M. Thompson,
D. Podzamczer,
J. Molina,
...
S. Oka,
E. Koenig,
B. Trottier,
J. Andrade-Villanueva,
G. Crofoot,
J. Custodio,
Andrew Plummer,
Lijie Zhong,
H. Cao,
Hal Martin,
C. Callebaut,
A. Cheng,
M. Fordyce,
S. McCallister
|
9 |
2015 |
9
π
|
|
π
|
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
45 auth.
A. Falsey,
M. Sobieszczyk,
I. Hirsch,
Stephanie Sproule,
M. Robb,
L. Corey,
K. Neuzil,
William W Hahn,
Julie Hunt,
M. Mulligan,
C. Mcevoy,
E. Dejesus,
Michael Hassman,
S. Little,
B. Pahud,
...
A. Durbin,
P. Pickrell,
E. Daar,
L. Bush,
Joel Solis,
Quito Osuna Carr,
Temitope Oyedele,
S. Buchbinder,
J. Cowden,
Sergio L Vargas,
Alfredo Guerreros Benavides,
R. Call,
M. Keefer,
B. Kirkpatrick,
J. Pullman,
T. Tong,
Margaret Brewinski Isaacs,
David C. Benkeser,
H. Janes,
M. Nason,
Justin A. Green,
E. Kelly,
Jill Maaske,
N. Mueller,
Kathryn Shoemaker,
Therese Takas,
Richard P. Marshall,
M. Pangalos,
T. Villafana,
Antonio Gonzalez-Lopez
|
8 |
2021 |
8
π
|
|
π
|
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks
15 auth.
P. Sax,
E. Dejesus,
A. Mills,
A. Zolopa,
C. Cohen,
D. Wohl,
J. Gallant,
Hui C. Liu,
Lijie Zhong,
Kitty Yale,
...
K. White,
B. Kearney,
J. Szwarcberg,
E. Quirk,
A. Cheng
|
8 |
2012 |
8
π
|
|
π
|
Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48
12 auth.
Roberto Ortiz,
E. Dejesus,
H. Khanlou,
Evgeniy Voronin,
J. van Lunzen,
J. Andrade-Villanueva,
...
J. Fourie,
S. De Meyer,
M. de Pauw,
E. Lefebvre,
T. Vangeneugden,
S. SpinosaβGuzman
|
8 |
2008 |
8
π
|
|
π
|
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
21 auth.
J. Eron,
B. Young,
D. Cooper,
M. Youle,
E. Dejesus,
J. Andrade-Villanueva,
C. Workman,
R. Zajdenverg,
G. FΓ€tkenheuer,
D. Berger,
...
Princy N. Kumar,
A. Rodgers,
M. Shaughnessy,
Monica L Walker,
Richard J. O. Barnard,
Michael D. Miller,
M. Dinubile,
B. Nguyen,
R. Leavitt,
Xia Xu,
P. Sklar
|
8 |
2010 |
8
π
|
|
π
|
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
16 auth.
J. Eron,
P. Yeni,
J. Gathe,
V. Estrada,
E. Dejesus,
S. Staszewski,
Philip C. Lackey,
C. Katlama,
B. Young,
L. Yau,
...
Denise H. Sutherland-Phillips,
P. Wannamaker,
C. Vavro,
Lisa G Patel,
J. Yeo,
M. Shaefer
|
8 |
2006 |
8
π
|
